biologic

Abecma

idecabtagene vicleucel

Loss of exclusivity—loss of exclusivity

CompanyCelgene Corporation, a Bristol-Myers Squibb Company

Drug detail

Brand name	Abecma
Active ingredient	idecabtagene vicleucel
Strength	300 to 510 X 10^6 CHIMERIC ANTIGEN RECEPTOR (CAR)-POSITIVE T CELLS
Dosage form	Suspension
Route	Intravenous
Modality	Biologic
Marketing status	Rx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.